Examples include abatacept (CTLA4-Fc) in treating rheumatoid arthritis (5), psoriatic arthritis (29) and juvenile idiopathic arthritis (30) and belatacept (an engineered version of CTLA4-Fc) in preventing transplant rejection (18, 19). This evidence concerns the gene CTLA4 and juvenile idiopathic arthritis.